Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy

BACKGROUND: While it is well known that teriparatide (TPTD) increases bone mineral density (BMD) in osteoporotic patients, it is unknown whether TPTD pretreatment affects BMD after denosumab (DMAb) therapy. METHODS: Fifty-seven patients in TPTD-pretreated group and 35 patients in DMAb-alone group ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamimura, Mikio, Taguchi, Akira, Nakamura, Yukio, Koiwai, Hidefumi, Ikegami, Shota, Uchiyama, Shigeharu, Kato, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892610/
https://www.ncbi.nlm.nih.gov/pubmed/29662314
http://dx.doi.org/10.2147/TCRM.S154686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892610/
https://www.ncbi.nlm.nih.gov/pubmed/29662314
http://dx.doi.org/10.2147/TCRM.S154686

Ejemplares similares